ব'ৱেল (ক'ল'ৰেক্টেল) কেন্সাৰ

The goal of this clinical trial is to evaluate whether Nuvastatic can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic significantly reduce cancer-related fatigue compared to placebo? Is Nuvastatic safe and well tolerated in this patient population? Researchers will compare Nuvastatic vs placebo to see if Nuvastatic improves fatigue scores and maintains an acceptable safety profile. Participants will: Receive Nuvastatic or placebo sachets (3 times per day) for 3 cycles of 20 days…

স্পনচৰ: নেচাৰচিউটিকলছ এছডিএন বিএইচডি
ClinicalTrials.gov-ত NCT07669519
ৰেজিষ্ট্ৰীত অন্তিম আপডেট ২৫ আগষ্ট ২০২৬ · আমি পঢ়িছোঁ ২০ অক্টোবৰ ২০২৬